Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole + Goserelin vs Letrozole Alone in Metastatic Breast Cancer
NCT00532272Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2005
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Oct 2005; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00532272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532272.